| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were cancellation of warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were cancellation of warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, cancellation of warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of cancellation of shares award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Aggregate Intrinsic Value, Exercise of prefunded warrants. No definition available.
|
| X | ||||||||||
- Definition Aggregate Intrinsic Value, Exercise of Series D Warrants from February Offering. No definition available.
|
| X | ||||||||||
- Definition Aggregate Intrinsic Value, Issued February 2025 Offering. No definition available.
|
| X | ||||||||||
- Definition Aggregate Intrinsic Value, Issued prefunded warrants. No definition available.
|
| X | ||||||||||
- Definition Aggregate Intrinsic Value, Outstanding and Exercisable at beginning. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercise of series D warrants from february offering. No definition available.
|
| X | ||||||||||
- Definition Net number of non-option equity instruments issued prefunded warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price,Exercise of Series D Warrants from February Offering. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price, Expired warrants. No definition available.
|
| X | ||||||||||
- Definition Net number of non-option equity instruments weighted average exercise price, issued pursuant to august 2024 offering. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price, Issued prefunded warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Life In Years, Outstanding and Exercisable at beginning and ending. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Life In Years, Exercise of prefunded warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Life In Years, Exercise of Series D Warrants from February Offering. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Life In Years, Issued February 2025 Offering. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Life In Years, Issued prefunded warrants. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|